Global Meningococcal Infections Treatment Market Growth (Status and Outlook) 2025-2031

September 2025 | 79 pages | ID: G2F8050C2AFEN
LP Information

Abstracts

According to this study, the global Meningococcal Infections Treatment market size will reach US$ million by 2031.

Meningococcal meningitis are a major cause of bacterial meningitis and septicemia, usually occurs during infancy, adolescence and young adulthood and is characterized by an infectious syndrome with meningismus. Aggressive early treatment of meningococcal disease can reduce mortality.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Meningococcal Infections Treatment Industry Forecast” looks at past sales and reviews total world Meningococcal Infections Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Meningococcal Infections Treatment sales for 2025 through 2031. With Meningococcal Infections Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Meningococcal Infections Treatment industry.

This Insight Report provides a comprehensive analysis of the global Meningococcal Infections Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Meningococcal Infections Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Meningococcal Infections Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Meningococcal Infections Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Meningococcal Infections Treatment.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Infections Treatment market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Antibiotics
• Glucocorticoids
• Protein C Concentrate

Segmentation by Application:

• Hospitals
• Clinics
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Pfizer
• Sanofi
• GlaxoSmithKline
• Novartis

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Meningococcal Infections Treatment Market Size (2020-2031)
  2.1.2 Meningococcal Infections Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Meningococcal Infections Treatment by Country/Region (2020, 2024 & 2031)
2.2 Meningococcal Infections Treatment Segment by Type
  2.2.1 Antibiotics
  2.2.2 Glucocorticoids
  2.2.3 Protein C Concentrate
2.3 Meningococcal Infections Treatment Market Size by Type
  2.3.1 Meningococcal Infections Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Meningococcal Infections Treatment Market Size Market Share by Type (2020-2025)
2.4 Meningococcal Infections Treatment Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Others
2.5 Meningococcal Infections Treatment Market Size by Application
  2.5.1 Meningococcal Infections Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Meningococcal Infections Treatment Market Size Market Share by Application (2020-2025)

3 MENINGOCOCCAL INFECTIONS TREATMENT MARKET SIZE BY PLAYER

3.1 Meningococcal Infections Treatment Market Size Market Share by Player
  3.1.1 Global Meningococcal Infections Treatment Revenue by Player (2020-2025)
  3.1.2 Global Meningococcal Infections Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Meningococcal Infections Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MENINGOCOCCAL INFECTIONS TREATMENT BY REGION

4.1 Meningococcal Infections Treatment Market Size by Region (2020-2025)
4.2 Global Meningococcal Infections Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Meningococcal Infections Treatment Market Size Growth (2020-2025)
4.4 APAC Meningococcal Infections Treatment Market Size Growth (2020-2025)
4.5 Europe Meningococcal Infections Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Meningococcal Infections Treatment Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Meningococcal Infections Treatment Market Size by Country (2020-2025)
5.2 Americas Meningococcal Infections Treatment Market Size by Type (2020-2025)
5.3 Americas Meningococcal Infections Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Meningococcal Infections Treatment Market Size by Region (2020-2025)
6.2 APAC Meningococcal Infections Treatment Market Size by Type (2020-2025)
6.3 APAC Meningococcal Infections Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Meningococcal Infections Treatment Market Size by Country (2020-2025)
7.2 Europe Meningococcal Infections Treatment Market Size by Type (2020-2025)
7.3 Europe Meningococcal Infections Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Meningococcal Infections Treatment by Region (2020-2025)
8.2 Middle East & Africa Meningococcal Infections Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Meningococcal Infections Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MENINGOCOCCAL INFECTIONS TREATMENT MARKET FORECAST

10.1 Global Meningococcal Infections Treatment Forecast by Region (2026-2031)
  10.1.1 Global Meningococcal Infections Treatment Forecast by Region (2026-2031)
  10.1.2 Americas Meningococcal Infections Treatment Forecast
  10.1.3 APAC Meningococcal Infections Treatment Forecast
  10.1.4 Europe Meningococcal Infections Treatment Forecast
  10.1.5 Middle East & Africa Meningococcal Infections Treatment Forecast
10.2 Americas Meningococcal Infections Treatment Forecast by Country (2026-2031)
  10.2.1 United States Market Meningococcal Infections Treatment Forecast
  10.2.2 Canada Market Meningococcal Infections Treatment Forecast
  10.2.3 Mexico Market Meningococcal Infections Treatment Forecast
  10.2.4 Brazil Market Meningococcal Infections Treatment Forecast
10.3 APAC Meningococcal Infections Treatment Forecast by Region (2026-2031)
  10.3.1 China Meningococcal Infections Treatment Market Forecast
  10.3.2 Japan Market Meningococcal Infections Treatment Forecast
  10.3.3 Korea Market Meningococcal Infections Treatment Forecast
  10.3.4 Southeast Asia Market Meningococcal Infections Treatment Forecast
  10.3.5 India Market Meningococcal Infections Treatment Forecast
  10.3.6 Australia Market Meningococcal Infections Treatment Forecast
10.4 Europe Meningococcal Infections Treatment Forecast by Country (2026-2031)
  10.4.1 Germany Market Meningococcal Infections Treatment Forecast
  10.4.2 France Market Meningococcal Infections Treatment Forecast
  10.4.3 UK Market Meningococcal Infections Treatment Forecast
  10.4.4 Italy Market Meningococcal Infections Treatment Forecast
  10.4.5 Russia Market Meningococcal Infections Treatment Forecast
10.5 Middle East & Africa Meningococcal Infections Treatment Forecast by Region (2026-2031)
  10.5.1 Egypt Market Meningococcal Infections Treatment Forecast
  10.5.2 South Africa Market Meningococcal Infections Treatment Forecast
  10.5.3 Israel Market Meningococcal Infections Treatment Forecast
  10.5.4 Turkey Market Meningococcal Infections Treatment Forecast
10.6 Global Meningococcal Infections Treatment Forecast by Type (2026-2031)
10.7 Global Meningococcal Infections Treatment Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Meningococcal Infections Treatment Forecast

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Meningococcal Infections Treatment Product Offered
  11.1.3 Pfizer Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Pfizer Main Business Overview
  11.1.5 Pfizer Latest Developments
11.2 Sanofi
  11.2.1 Sanofi Company Information
  11.2.2 Sanofi Meningococcal Infections Treatment Product Offered
  11.2.3 Sanofi Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Sanofi Main Business Overview
  11.2.5 Sanofi Latest Developments
11.3 GlaxoSmithKline
  11.3.1 GlaxoSmithKline Company Information
  11.3.2 GlaxoSmithKline Meningococcal Infections Treatment Product Offered
  11.3.3 GlaxoSmithKline Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 GlaxoSmithKline Main Business Overview
  11.3.5 GlaxoSmithKline Latest Developments
11.4 Novartis
  11.4.1 Novartis Company Information
  11.4.2 Novartis Meningococcal Infections Treatment Product Offered
  11.4.3 Novartis Meningococcal Infections Treatment Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Novartis Main Business Overview
  11.4.5 Novartis Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Meningococcal Infections Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Meningococcal Infections Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Antibiotics
Table 4. Major Players of Glucocorticoids
Table 5. Major Players of Protein C Concentrate
Table 6. Meningococcal Infections Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Meningococcal Infections Treatment Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Meningococcal Infections Treatment Market Size Market Share by Type (2020-2025)
Table 9. Meningococcal Infections Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Meningococcal Infections Treatment Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Meningococcal Infections Treatment Market Size Market Share by Application (2020-2025)
Table 12. Global Meningococcal Infections Treatment Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Meningococcal Infections Treatment Revenue Market Share by Player (2020-2025)
Table 14. Meningococcal Infections Treatment Key Players Head office and Products Offered
Table 15. Meningococcal Infections Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Meningococcal Infections Treatment Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Meningococcal Infections Treatment Market Size Market Share by Region (2020-2025)
Table 20. Global Meningococcal Infections Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Meningococcal Infections Treatment Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Meningococcal Infections Treatment Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Meningococcal Infections Treatment Market Size Market Share by Country (2020-2025)
Table 24. Americas Meningococcal Infections Treatment Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Meningococcal Infections Treatment Market Size Market Share by Type (2020-2025)
Table 26. Americas Meningococcal Infections Treatment Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Meningococcal Infections Treatment Market Size Market Share by Application (2020-2025)
Table 28. APAC Meningococcal Infections Treatment Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Meningococcal Infections Treatment Market Size Market Share by Region (2020-2025)
Table 30. APAC Meningococcal Infections Treatment Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Meningococcal Infections Treatment Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Meningococcal Infections Treatment Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Meningococcal Infections Treatment Market Size Market Share by Country (2020-2025)
Table 34. Europe Meningococcal Infections Treatment Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Meningococcal Infections Treatment Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Meningococcal Infections Treatment Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Meningococcal Infections Treatment Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Meningococcal Infections Treatment Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Meningococcal Infections Treatment
Table 40. Key Market Challenges & Risks of Meningococcal Infections Treatment
Table 41. Key Industry Trends of Meningococcal Infections Treatment
Table 42. Global Meningococcal Infections Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Meningococcal Infections Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Meningococcal Infections Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Meningococcal Infections Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Pfizer Details, Company Type, Meningococcal Infections Treatment Area Served and Its Competitors
Table 47. Pfizer Meningococcal Infections Treatment Product Offered
Table 48. Pfizer Meningococcal Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Pfizer Main Business
Table 50. Pfizer Latest Developments
Table 51. Sanofi Details, Company Type, Meningococcal Infections Treatment Area Served and Its Competitors
Table 52. Sanofi Meningococcal Infections Treatment Product Offered
Table 53. Sanofi Meningococcal Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Sanofi Main Business
Table 55. Sanofi Latest Developments
Table 56. GlaxoSmithKline Details, Company Type, Meningococcal Infections Treatment Area Served and Its Competitors
Table 57. GlaxoSmithKline Meningococcal Infections Treatment Product Offered
Table 58. GlaxoSmithKline Meningococcal Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. GlaxoSmithKline Main Business
Table 60. GlaxoSmithKline Latest Developments
Table 61. Novartis Details, Company Type, Meningococcal Infections Treatment Area Served and Its Competitors
Table 62. Novartis Meningococcal Infections Treatment Product Offered
Table 63. Novartis Meningococcal Infections Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Novartis Main Business
Table 65. Novartis Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Meningococcal Infections Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Meningococcal Infections Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Meningococcal Infections Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Meningococcal Infections Treatment Sales Market Share by Country/Region (2024)
Figure 8. Meningococcal Infections Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Meningococcal Infections Treatment Market Size Market Share by Type in 2024
Figure 10. Meningococcal Infections Treatment in Hospitals
Figure 11. Global Meningococcal Infections Treatment Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Meningococcal Infections Treatment in Clinics
Figure 13. Global Meningococcal Infections Treatment Market: Clinics (2020-2025) & ($ millions)
Figure 14. Meningococcal Infections Treatment in Others
Figure 15. Global Meningococcal Infections Treatment Market: Others (2020-2025) & ($ millions)
Figure 16. Global Meningococcal Infections Treatment Market Size Market Share by Application in 2024
Figure 17. Global Meningococcal Infections Treatment Revenue Market Share by Player in 2024
Figure 18. Global Meningococcal Infections Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Meningococcal Infections Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Meningococcal Infections Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Meningococcal Infections Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Meningococcal Infections Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Meningococcal Infections Treatment Value Market Share by Country in 2024
Figure 24. United States Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Meningococcal Infections Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Meningococcal Infections Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Meningococcal Infections Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Meningococcal Infections Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Meningococcal Infections Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Meningococcal Infections Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Meningococcal Infections Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Meningococcal Infections Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Meningococcal Infections Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Meningococcal Infections Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Meningococcal Infections Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Meningococcal Infections Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Meningococcal Infections Treatment Market Size 2026-2031 ($ millions)